CIK 0001561921
- Non-accelerated filer
- Smaller reporting company
TELA Bio, Inc.
Sign in to watch- Ticker
- TELA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455320061
- Phone
- +1 484-320-2930
- Business address
- 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
- Open-market buys, last 90 days
- $167,238
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$167,238. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-13 | Friedman Ashley Director | Conversion · Series B Preferred Stock | −1,479,951 | 0 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion · Series B Preferred Stock | −7,051,009 | 0 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion · Warrant (right to buy) | −31,168 | 0 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion · Warrant (right to buy) | +31,168 | 31,168 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion · Warrant (right to buy) | −148,499 | 0 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion · Warrant (right to buy) | +148,499 | 148,499 | ||
| 2019-11-13 | Oliva Adele C Director | Conversion | +345,489 | 1,234,153 | ||
| 2019-11-13 | Oliva Adele C Director | Conversion | +516,947 | 1,751,100 | ||
| 2019-11-13 | Oliva Adele C Director | Conversion · Series A Preferred Stock | −8,530,145 | 0 | ||
| 2019-11-13 | Oliva Adele C Director | Conversion · Series B Preferred Stock | −12,763,434 | 0 | ||
| 2019-11-13 | Oliva Adele C Director | Conversion · Warrant (right to buy) | −446,813 | 0 | ||
| 2019-11-13 | Oliva Adele C Director | Conversion · Warrant (right to buy) | +446,813 | 446,813 | ||
| 2019-11-13 | ORBIMED ADVISORS LLC 10% owner | Conversion | +481,095 | 2,049,722 | ||
| 2019-11-13 | ORBIMED ADVISORS LLC 10% owner | Conversion | +977,820 | 3,027,542 | ||
| 2019-11-13 | ORBIMED ADVISORS LLC 10% owner | Conversion · Series A Preferred Stock | −11,878,249 | 0 | ||
| 2019-11-13 | ORBIMED ADVISORS LLC 10% owner | Conversion · Series B Preferred Stock | −24,142,419 | 0 | ||
| 2019-11-13 | ORBIMED ADVISORS LLC 10% owner | Conversion · Warrant (right to buy) | −758,623 | 0 | ||
| 2019-11-13 | ORBIMED ADVISORS LLC 10% owner | Conversion · Warrant (right to buy) | +758,623 | 758,623 | ||
| 2019-11-08 | Quaker BioVentures II LP 10% owner | Purchase | +153,846 | $13.00 | $2.0M | 888,664 |
| 2019-11-08 | Zuga Matt Director | Purchase | +10,220 | $13.00 | $133K | 12,675 |
Page 28 of 29 · 565 trades